Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
D002839:Chromans / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003257:Consumer Product Safety; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004345:Drug Industry; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077205:Pioglitazone; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone; D014481:United States
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone; D000077205:Pioglitazone